glp-1 and kidney function GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Role of GLP-1 Agonists &

Can GLP-1 medications cause shortness of breath

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Personalized diet and exercise interventions, alongside pharmacological treatments, are crucial for enhancing both metabolic and psychological outcomes, ensuring a more sustainable and effective approach to managing obesity

Dive into our articles that blend the joy of candy with valuable insights on health and lifestyle.

Clinician-guided, low-dose, two pathways

Read highlights from the released 2025 Standards of Care, including recommendations for CGM use in type 2 diabetes for the first time, the use of GLP-1 drugs for kidney and heart benefits and a warning of DKA risk in recreational marijuana use.